Tissue Transglutaminase Antibody, IgA

Tissue transglutaminase (tTG) is an enzyme that plays an important role in various biological processes. One of its key functions is to help in the formation of stable protein structures by catalyzing the binding of proteins. tTG enzyme is implicated in the immune response triggered by gluten (a protein found in cereals like wheat, barley, and rye and foods like cakes, bread, and pasta)  consumption.

In individuals with celiac disease, exposure to gluten often prompts an abnormal immune response where antibodies, including anti-tissue transglutaminase antibodies, are produced. These antibodies target the tTG enzyme, causing characteristic damage to the lining of the small intestine. Untreated celiac disease can lead to potential complications like malabsorption, malnutrition, weakened bones (osteoporosis), fertility problems, or an increased risk of intestinal cancer. It may also increase the risk of developing other autoimmune conditions like rheumatoid arthritis. 

A Tissue Transglutaminase Antibody, IgA test helps in the diagnosis and timely management of celiac disease in individuals experiencing digestive problems, unexplained symptoms such as chronic diarrhea, bloating, stomach pain, etc. suggestive of celiac disease, or those with a family history of celiac disease or having risk factors such as diabetes, thyroid problems etc. 

No special preparation is required before undertaking a Tissue Transglutaminase Antibody, IgA test. However, to diagnose celiac disease, the test should be performed before eliminating gluten from the diet. 

Lab test results may vary across different laboratories. Abnormal test results require an expert interpretation, therefore, never try to self-medicate at home based solely on these results, and always consult a doctor for proper understanding of the test results. The insights from a Tissue Transglutaminase Antibody, IgA test are valuable in the pursuit of an accurate diagnosis and effective management of celiac disease.